Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Immunocore Holdings (IMCR) Other Non-Current Liabilities (2022 - 2025)

Historic Other Non-Current Liabilities for Immunocore Holdings (IMCR) over the last 4 years, with Q3 2025 value amounting to $96.6 million.

  • Immunocore Holdings' Other Non-Current Liabilities rose 311370.59% to $96.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $96.6 million, marking a year-over-year increase of 311370.59%. This contributed to the annual value of $978000.0 for FY2023, which is 5584.65% down from last year.
  • Latest data reveals that Immunocore Holdings reported Other Non-Current Liabilities of $96.6 million as of Q3 2025, which was up 311370.59% from $84.0 million recorded in Q2 2025.
  • In the past 5 years, Immunocore Holdings' Other Non-Current Liabilities ranged from a high of $96.6 million in Q3 2025 and a low of $978000.0 during Q4 2023
  • In the last 4 years, Immunocore Holdings' Other Non-Current Liabilities had a median value of $2.6 million in 2022 and averaged $31.7 million.
  • Its Other Non-Current Liabilities has fluctuated over the past 5 years, first tumbled by 5584.65% in 2023, then surged by 391914.79% in 2025.
  • Over the past 4 years, Immunocore Holdings' Other Non-Current Liabilities (Quarter) stood at $2.2 million in 2022, then tumbled by 55.85% to $978000.0 in 2023, then surged by 207.36% to $3.0 million in 2024, then surged by 3113.71% to $96.6 million in 2025.
  • Its Other Non-Current Liabilities stands at $96.6 million for Q3 2025, versus $84.0 million for Q2 2025 and $62.5 million for Q1 2025.